Progress towards water-soluble triazole-based selective MMP-2 inhibitors.

dc.centroUniversidad San Pablo-CEU
dc.contributor.authorRamos González, Ana María
dc.contributor.authorMartínez Alcázar, María Paz
dc.contributor.authorPascual-Teresa Fernández, Beatriz de
dc.contributor.authorZapico Rodríguez, José María
dc.contributor.authorFabre, Benjamin
dc.contributor.authorFilipiak, Kamila
dc.date2013es
dc.date.accessioned2015-09-26T04:00:14Z
dc.date.available2015-09-26T04:00:14Z
dc.date.issued2013-09-26
dc.descriptionEn: Organic and Biomolecular Chemistry. EISSN. 1477-0539. 2013, 11, 6623-6641, doi: 10.1039/c3ob41046ces
dc.description.abstractWater solubility is a key aspect that needs to be addressed to obtain druglike compounds. In an effort to improve the water solubility of our recently reported nanomolar matrix metalloproteinase type 2 (MMP10 2) inhibitors based on triazole-substituted hydroxamates, we synthesized a new series of -sulfone, - tetrahydropyran and -piperidine, -sulfone clicked hydroxamates and determined their inhibitory activities against both MMP-2 and MMP-9. The best results were found for 13e, a water-soluble compound that displays a low nanomolar activity against MMP-2 and is 26-fold less active against MMP9. This finding allowed us to pursue in vitro permeability through Caco-2 monolayer and open the 15 possibility for carrying out further preclinical investigations. Docking and MD simulations have been performed in order to rationalize the biological results. The inhibitory activity of this compound against a panel of ten MMPs was determined showing an interesting MMP-2/MMP-1,-8,-14 selectivity profile. The cytotoxicity and anti-invasive activity of the compounds on highly metastatic human fibrosarcoma tumor cells (HT1080) were determined, showing, at 10 M concentration, a decrease in cell invasiveness up to 20 80 %.en_EN
dc.description.versionPost-print del autores
dc.formatapplication/pdfes
dc.identifier000000625343es
dc.identifier.urihttp://hdl.handle.net/10637/7721
dc.language.isoenes
dc.relationFinanciado con cargo a proyectos de I+D nacional con referencias (SAF2008-00945, CTQ2011-24741, CTQ2007-105 63226, and SAF2011-28350).es
dc.rights.cchttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subjectMetaloproteínases
dc.subjectAnálisis
dc.titleProgress towards water-soluble triazole-based selective MMP-2 inhibitors.es
dc.typeArtículoes
dspace.entity.typePublicationes
europeana.dataProviderUNIVERSIDAD SAN PABLO CEU
europeana.isShownAthttp://hdl.handle.net/10637/7721
europeana.objecthttp://repositorioinstitucional.ceu.es/visor/libros/625343/thumb_europeana/625343.jpg
europeana.providerHispana
europeana.rightshttp://creativecommons.org/publicdomain/zero/1.0/
europeana.typeTEXT
relation.isAuthorOfPublicationac3c2128-fa85-4881-a056-bbeb0e359a4b
relation.isAuthorOfPublicationd7fb1206-a4e0-4fe5-8508-38114fa5bbcf
relation.isAuthorOfPublicationbe1dfee9-8e20-4fb0-bd00-a74857f4e0f8
relation.isAuthorOfPublication.latestForDiscoveryac3c2128-fa85-4881-a056-bbeb0e359a4b

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Progress_Fabre_Organic&BiomolChem_2013.pdf
Size:
956.99 KB
Format:
Adobe Portable Document Format